 |
|
| -L-
|
| Lactobacilli |
| Barker J, Meletis CD. Functional foods for childhood development. Alt Comp Therap 2004;10(3):131-134.
|
| Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 2004;3:19 doi: 10.1186/1475-2891-3-19.
|
| Harding KL, Judah RD, Grant CE. Outcome-based comparison of Ritalin versus food-supplement treated children with AD/HD. Alt Med Rev 2003;8(3):319-330.
|
| Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001;73(suppl):437S-443S.
|
| Sullivan A, Ford CE. Probiotics in human infections. J Antimicrobial Chemotherapy 2002;50:625-627.
|
| Lead |
| Harding KL, Judah RD, Grant CE. Outcome-based comparison of Ritalin versus food-supplement treated children with AD/HD. Alt Med Rev 2003;8(3):319-330.
|
| Kidd PM. Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Alt Med Rev 2000;5(5):402-428.
|
| Learning |
| Kidd PM. Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Alt Med Rev 2000;5(5):402-428.
|
| Qiao CX, Den R, Kudo K, Yamada K, Takemoto K, Wati H, Kanba S. Ginseng enhances contextual fear conditioning and neurogenesis in rats. Neurosci Res 2005;51:31-38.
|
| Lecithin |
| Milliman WB, Lamson DW, Brignall MS. Hepatitis C: a retrospective study, literature review, and naturopathic protocol. Alt Med Rev 2000;5(4):355-370.
|
| Leishmania donovani |
| Kolodziej H, Kayser O, Kiderlen AF, Ito H, Hatano T, Yoshida T, Foo LY. Proanthocyanidins and related compounds: antileishmanial activity and modulatory effects on nitric oxide and tumor necrosis factor-alpha-release in the murine macrophage-like cell line RAW 264.7. Biol Pharm Bull 2001;24(9):1016-1021.
|
| Leukemia
|
| Aggarwal BB, Bhardwa A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004;24(5A):2783-2841.
|
| Aziz MA, Kumar R, Ahmad. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol 2003;23:17-28.
|
| Borek C. Dietary antioxidants and human cancer. Integ Cancer Therap 2004;3(4):333-341.
|
| Gao X, Xu YX, Divine G, Janakiraman N, Chapman RA, Gautam SC. Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J Nutr 2002;132:2076-2081.
|
| Kagan VE, Yalowich JC, Borisenko GG, Tyurina YY, Tyurin V, Thampatty P, Fabisiak JP. Mechanism-based chemopreventive strategies against etoposide-induced acute myeloid leukemia: free radical/antioxidant approach. Mol Pharm 1999;56:494-506.
|
| |
| Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Alt Med Rev 1999;4(5):304-329.
|
| Papageorgiou M, Stiakaki E, Dimitriou H, Malliaraki N, Notas G, Castanas E, Kalmanti M. Cancer chemotherapy reduces plasma total antioxidant capacity in children with malignancies. Leuk Res 2005;29:11-16.
|
| Prasad KN. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity. Integrat Cancer Therap 2004;3(4):310-322.
|
| Rapport L, Lockwood B. Proanthocyanidins and grape seed extract. Pharm J 2001;266:581-584.
|
| Shi J, Yu J, Pohorly JE, Kakuda Y. Polyphyenolics in grape seeds - biochemistry and functionality. J Med Food 2003;6(4):291-299.
|
| Leukopenia |
| Kidd PM. Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Alt Med Rev 2000;5(5):402-428.
|
| Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 2000;5(4):334-346.
|
| Leukoplakia |
| Koo MWL, Cho CH. Pharmacological effects of green tea on the gastrointestinal system. Euro J Pharmacol 2004;500:177-185.
|
| Limb-Girdle Dystrophy |
| Folkers K, Wolaniuk J, Simonsen R, Morishita M, Vadhanavikit S. Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10. Proc Natl Acad Sci 1985;82:4513-4516.
|
| Liver |
| Aggarwal BB, Bhardwa A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004;24(5A):2783-2841.
|
| Aziz MA, Kumar R, Ahmad. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol 2003;23:17-28.
|
| Can A, Akev N, Ozsov N, Bolkent S, Arda BP, Yanardag R, Okyar A. Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol Pharm Bull 2004;27(5):694-698.
|
| Chen A, Zhang L, Xu J and Tang J. The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. Biochem J 2002;368:695-704.
|
| Fujiki H, Sugnanuma M, Matsuyama S, Miyazaki K. Cancer prevention with green tea polyphenols for the general population, and for patients following cancer treatment. Curr Cancer Therap Rev 2005;1(1):109-114.
|
| Kang JS, Jeon YJ, Park SK, Yang KH, Kim HM. Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1B and prostaglandin E2 synthesis by silymarin. Biochem Pharacol 2004;67:175-181.
|
| Kidd PM. Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Alt Med Rev 2000;5(5):402-428.
|
| Lin JK, Tsai SH. Chemoprevention of cancer and cardiovascular disease by resveratrol. Proc Natl Sci Counc 1999;23(3):99-106.
|
| Milliman WB, Lamson DW, Brignall MS. Hepatitis C: a retrospective study, literature review, and naturopathic protocol. Alt Med Rev 2000;5(4):355-370.
|
| Monograph. Oligomeric Proanthocyanidins (OPCs). Alt Med Rev 2003;8(4):442-450.
|
| |
| Yamada Y, Nakajima A, Sekihara H. Anti-apoptotic effect of dehydroepiandrosterone and its role in an aging society. Int Med 2004;43(2):158-160.
|
| Liver Toxicity |
| Abascal K, Yarnell E. The many faces of Silybum marianum (milk thistle), part 1 - treating cancer and hyperlipidemia and restoring kidney function. Alt Comp Therapy 2003;9(4):170-175.
|
| Abascal K, Yarnell E. The many faces of Silybum marianum (milk thistle), part 2 - clinical uses, safety, and types of preparations. Alt Comp Therapy 2003;9(5):251-257.
|
| Borek C. Antioxidant health effects of aged garlic extract. J Nutr 2001;131:1010S-1015S.
|
| Can A, Akev N, Ozsov N, Bolkent S, Arda BP, Yanardag R, Okyar A. Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol Pharm Bull 2004;27(5):694-698.
|
| Chen A, Zhang L, Xu J and Tang J. The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. Biochem J 2002;368:695-704.
|
| Gupta R, Flora SJS. Protective value of Aloe vera against some toxic effects of arsenic in rats. Phytother Res 2005;1923-28.
|
| Kang JS, Jeon YJ, Park SK, Yang KH, Kim HM. Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1B and prostaglandin E2 synthesis by silymarin. Biochem Pharacol 2004;67:175-181.
|
| Milliman WB, Lamson DW, Brignall MS. Hepatitis C: a retrospective study, literature review, and naturopathic protocol. Alt Med Rev 2000;5(4):355-370.
|
| Yamada Y, Nakajima A, Sekihara H. Anti-apoptotic effect of dehydroepiandrosterone and its role in an aging society. Int Med 2004;43(2):158-160.
|
| Lovastatin |
| Willis RA, Folkers K, Tucker JL, Ye CQ, Xia LJ, Tamagawa H. Lovastatin decreases coenzyme Q levels in rats. Proc Natl Acad Sci 1990;87:8928-8930.
|
| Low Back Pain |
| Preyde M. Effectiveness of massage therapy for subacute low-back pain: a randomized controlled trial. CMAJ 2000;162(13):1815-1820.
|
| Lung |
| Aggarwal BB, Bhardwa A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004;24(5A):2783-2841.
|
| Aziz MA, Kumar R, Ahmad. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol 2003;23:17-28.
|
| Barnard RJ. Prevention of cancer through lifestyle changes. eCAM 2004;1(3):233-239.
|
| Borek C. Dietary antioxidants and human cancer. Integ Cancer Therap 2004;3(4):333-341.
|
| Corsini E, Lucchi L, Meroni M, Racchi M, Solerte B, Fioravanti M, Viviani B, Marinovich M, Govoni S, Galli CL. In vivo dehydroepiandrosterone restores age-associated defects in the protein kinase C signal transduction pathway and related functional responses. J Immunol 2002;168:1753-1758.
|
| Di Paola R, Mazzon E, Muia C, Genovese T, Menegazzi M, Zaffini R, Suzuki H, Cuzzocrea S. Green tea polyphenol extract attenuates lung injury in experimental model of carrageenan-induced pleurisy in mice. Resp Res 2005,6:66 doi:10.1186/1465-9921-6-66.
|
| Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 2004;3:19 doi: 10.1186/1475-2891-3-19.
|
| Fischer H, Schwarzer C, Illek B. Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci USA 2004;101(10):3691-3696.
|
| Fujiki H, Sugnanuma M, Matsuyama S, Miyazaki K. Cancer prevention with green tea polyphenols for the general population, and for patients following cancer treatment. Curr Cancer Therap Rev 2005;1(1):109-114.
|
| Head KA. Isoflavones and other soy constituents in human health and disease. Altern Med Rev 1997;2(6):433-450.
|
| Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Alt Med Rev 1999;4(5):304-329.
|
| Monograph. Oligomeric Proanthocyanidins (OPCs). Alt Med Rev 2003;8(4):442-450.
|
| Mongraph. Vaccinium myrtillus (bilberry). Alt Med Rev 2001;6(1):500-504.
|
| O'Donovan DJ, Fernandes CJ. Free radicals and diseases in premature infants. Antioxid Redox Signal 2004;6(1):169-176.
|
| Prasad KN. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity. Integrat Cancer Therap 2004;3(4):310-322.
|
| Prasad KN, Kumar B, Yan XD, Hanson AJ, Cole WC. Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review. Am J Am Coll Nutr 2003;22(2):108-117.
|
| Rapport L, Lockwood B. Proanthocyanidins and grape seed extract. Pharm J 2001;266:581-584.
|
| Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N, Moore MA. Cancer prevention by natural compounds. Drug Metab Pharmacokin 2004;19(4):245-263.
|
|
| Lutein |
| Aleman TS, Duncan JL, Bieber ML, de Castro E, Marks DA, Gardner LM, Steinberg JD, Cideciyan AV, Maguire MG, Jacobson SG. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Opthamol Vis Sci 2001;42:1873-1881.
|
| Berendshot TTJM, Goldbohm RA, Klopping WAA, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 2000;41:3322-3326.
|
| Borek C. Dietary antioxidants and human cancer. Integ Cancer Therap 2004;3(4):333-341.
|
| Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 2004;3:19 doi: 10.1186/1475-2891-3-19.
|
| Mares-Perlman JA, Millen AE, Ficek TL, Hankinson SE. The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. J Nutr 2002;132:518S-524S.
|
| Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tspipursky, Nyland J. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (lutein antioxidant supplementation trial). Optom 2004;75(4):216-230.
|
| Lycopene |
| Agarwal S, Veketeshwer Rao A. Tomato lycopene and its role in human health and chronic diseases. CMAJ 2000;163(6):739-744.
|
| Borek C. Dietary antioxidants and human cancer. Integ Cancer Therap 2004;3(4):333-341.
|
| Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 2004;3:19 doi: 10.1186/1475-2891-3-19.
|
| Keck AS, Finley JW. Cruciferous vegetables: cancer protective mechanisms of glucosinolate hydrolysis products and selenium. Integ Cancer Therap 2004;3(1):5-12.
|
| Lamson DW, Brignall MS. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Alt Med Rev 1999;4(5):304-329.
|
| Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tspipursky, Nyland J. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (lutein antioxidant supplementation trial). Optom 2004;75(4):216-230.
|
| Ripple MO, Henry WF, Schwarze SR, Wilding G, Weindruch R. Effect of antioxidants on androgen-induced AP-1 and NF-KB DNA-binding activity in prostate carcinoma cells. J Natl Cancer Inst 1999;91:1227-1321.
|
| Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N, Moore MA. Cancer prevention by natural compounds. Drug Metab Pharmacokin 2004;19(4):245-263.
|
| Lymphedema |
| Monograph. Oligomeric Proanthocyanidins (OPCs). Alt Med Rev 2003;8(4):442-450.
|
| Lymphocyte |
| Tomasetti M, Alleva R, Borghi B, Collins AR. In vivo supplementation with coenzyme Q10 enhances the recovery of human lymphocytes from oxidative DNA damage. FASEB J 2001;15(8):1425-1427.
|
| Lymphoma |
| Aggarwal BB, Bhardwa A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004;24(5A):2783-2841.
|
| Andres E, Loukili H, Noel E, Kaltenbach G, Abdelgheni MB, Perrin AE, Noblet-Dick M, Maloisel F, Schlienger JL, Blickle JF. Vitamin B12 (cobalamin) deficiency in elderly patients. CMAJ 2004;171(3):251-259.
|
| Aziz MA, Kumar R, Ahmad. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol 2003;23:17-28.
|
| Jazirehi AR, Bonavida B. Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Can Therap 2004;3(1):71-84.
|
| Shacter E, Williams JA, Hinson RM, Senturker S, Lee YY. Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis. Blood 2000;96(1):307-313.
|
|
|
| |
